First-trimester prediction of macrosomia

Fetal Diagnosis and Therapy

Volumn 29, Issue 2, 2011, Pages 139-147

  Poon, Leona C Y ^a   Karagiannis, George ^a,b   Stratieva, Violeta ^a,b   Syngelaki, Argyro ^a,b   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Free human chorionic gonadotrophin; Macrosomia; Nuchal translucency; Pregnancy associated plasma protein A; Screening

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AFRICAN AMERICAN; ANEUPLOIDY; ARTICLE; ASIAN; BODY HEIGHT; BODY WEIGHT; CAUCASIAN; CHRONIC DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; EAST ASIAN; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MOTHER; NEGRO; NUCHAL TRANSLUCENCY MEASUREMENT; PARITY; PREDICTION; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH ASIAN;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETAL MACROSOMIA; FORECASTING; HUMANS; MASS SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 79952991341     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318565     Document Type: Article

References (58)

1. Berkus MD, Conway D, Langer O: The large fetus. Clin Obstet Gynecol 1999; 42: 766-784. (Pubitemid 30021846)
2. Bromwich P: Big babies. Br Med J (Clin Res Ed) 1986; 293: 1387-1388. (Pubitemid 17190282)
3. Ferber A: Maternal complications of fetal macrosomia. Clin Obstet Gynecol 2000; 43: 335-339. (Pubitemid 30450547)
4. Grassi AE, Giuliano MA: The neonate with macrosomia. Clin Obstet Gynecol 2000; 43: 340-348. (Pubitemid 30450548)
5. Spellacy WN, Miller S, Winegar A, Peterson PQ: Macrosomia -maternal characteristics and infant complications. Obstet Gynecol 1985; 66: 158-161. (Pubitemid 15049713)
6. Henriksen T: The macrosomic fetus: A challenge in current obstetrics. Acta Obstet Gynecol Scand 2008; 87: 134-145. (Pubitemid 351171533)
7. Gardosi J, Mongelli M, Mul T: Intrauterine growth retardation; in Steegers EAP, Eskes TKAB, Symonds EM (eds): Preventive care in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol 1995; 9: 445-643.
8. Gardosi J: New definition of small for gestational age based on fetal growth potential. Horm Res 2006; 65(suppl 3):15-18. (Pubitemid 44689428)
9. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP, Davis RO, DuBard MB: Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol 1990; 162: 53-58. (Pubitemid 20055420)
10. Clausson B, Cnattingius S, Axelsson O: Preterm and term births of small for gestational age infants: A population-based study of risk factors among nulliparous women. BJOG 1998; 105: 1011-1017. (Pubitemid 28442328)
11. Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH: First trimester maternal serum free β -human chorionic gonadotrophin and pregnancy-associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107: 1265-1270.
12. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z: Predicting complications of pregnancy with first-trimester maternal serum free-β -hCG, PAPP-A and inhibin-A. Prenat Diagn 2003; 23: 990-996. (Pubitemid 38004790)
13. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A: Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002; 22: 778-782.
14. Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM: Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767. (Pubitemid 34615266)
15. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME: First trimester maternal serum PAPP-A and free β -subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-1451. (Pubitemid 39421612)
16. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM, Cameron AD, Connor MJ, Dobbie R: Pregnancy-associated plasma protein A and α -fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006; 107: 161-166.
17. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH: First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 15-19. (Pubitemid 351211925)
18. Canini S, Prefumo F, Pastorino D, Crocetti L, Afflitto CG, Venturini PL, De Biasio P: Association between birth weight and firsttrimester free β -human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008; 89: 174-178.
19. Kelekci S, Yilmaz B, Savan K, Sonmez S: Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynecol 2005; 25: 579-582. (Pubitemid 43186906)
20. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346. (Pubitemid 28352196)
21. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH: Screening for trisomy 21 by maternal age, fetal NT, free β -hCG and PAPP-A. Ultrasound Obstet Gynecol 2008; 31: 618-624.
22. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH: Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates. Prenat Diagn 2010 (in press).
23. Zweig MH, Campbell G: Receiver-operating characteristic plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577. (Pubitemid 23118304)
24. Boulet SL, Alexander GR, Salihu HM, Pass M: Macrosomic births in the United States: Determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003; 188: 1372-1378. (Pubitemid 36589138)
25. Modanlou HD, Dorchester WL, Thorosian A, Freeman RK: Macrosomia -maternal, fetal, and neonatal implications. Obstet Gynecol 1980; 55: 420-424. (Pubitemid 10153757)
26. Davis R, Woelk G, Mueller BA, Daling J: The role of previous birthweight on risk for macrosomia in a subsequent birth. Epidemiology 1995; 6: 607-611.
27. Walsh CA, Mahony RT, Foley ME, Daly L, O'Herlihy C: Recurrence of fetal macrosomia in non-diabetic pregnancies. J Obstet Gynaecol 2007; 27: 374-378. (Pubitemid 47124335)
28. Mahony R, Walsh C, Foley ME, Daly L, O'Herlihy C: Outcome of second delivery after prior macrosomic infant in women with normal glucose tolerance. Obstet Gynecol 2006; 107: 857-862.
29. Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S: Risk factors for macrosomia and its clinical consequences: A study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111: 9-14. (Pubitemid 37230059)
30. Ramos GA, Caughey AB: The interrelationship between ethnicity and obesity on obstetric outcomes. Am J Obstet Gynecol 2005; 193: 1089-1093. (Pubitemid 41285499)
31. Mardones-Santander F, Salazar G, Rosso P, Villarroel L: Maternal body composition near term and birth weight. Obstet Gynecol 1998; 91: 873-877. (Pubitemid 28246916)
32. Lim JH, Tan BC, Jammal AE, Symonds EM: Delivery of macrosomic babies: Management and outcomes of 330 cases. J Obstet Gynaecol 2002; 22: 370-374.
33. Bergmann RL, Richter R, Bergmann KE, Plagemann A, Brauer M, Dudenhausen JW: Secular trends in neonatal macrosomia in Berlin: Influences of potential determinants. Paediatr Perinat Epidemiol 2003; 17: 244-249. (Pubitemid 36827921)
34. Kramer MS, Morin I, Yang H, Platt RW, Usher R, McNamara H, Joseph KS, Wen SW: Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr 2002; 141: 538-542. (Pubitemid 35193320)
35. Susa JB, Langer O: Diabetes and fetal growth; in Reece EA, Coustan DR (eds): Diabetes Mellitus in Pregnancy. New York, Churchill Livingstone, 1995, pp 79-92.
36. Maulik D: Fetal growth restriction: The etiology. Clin Obstet Gynecol 2006; 49: 228-235. (Pubitemid 44317912)
37. Gardosi J: The application of individualised fetal growth curves. J Perinat Med 1998; 26: 137-142. (Pubitemid 28368008)
38. Floyd RL, Rimer BK, Giovino GA, Mullen PD, Sullivan SE: A review of smoking in pregnancy: Effects on pregnancy outcomes and cessation efforts. Annu Rev Public Health 1993; 14: 379-411. (Pubitemid 23161726)
39. Ehrenberg HM, Mercer BM, Catalano PM: The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191: 964-968. (Pubitemid 39298142)
40. Clausen T, Burski TK, Oyen N, Godang K, Bollerslev J, Henriksen T: Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 2005; 153: 887-894. (Pubitemid 43020240)
41. Bo S, Menato G, Gallo ML, Bardelli C, Lezo A, Signorile A, Gambino R, Cassader M, Massobrio M, Pagano G: Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 2004; 83: 335-340. (Pubitemid 38406812)
42. Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T: Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001; 97: 776-780.
43. Freinkel N, Metzger B: Pregnancy as a tissue culture experience: The critical implications of maternal metabolism for fetal development. Ciba Found Symp 1978; 63: 3-28.
44. Soltani KH, Bruce C, Fraser RB: Observational study of maternal anthropometry and fetal insulin. Arch Dis Child Fetal Neonatal Ed 1999; 81:F122-F124. (Pubitemid 29398362)
45. Robinson S, Viira J, Learner J, Chan SP, Anyaoku V, Beard RW, Johnston DG: Insulin insensitivity is associated with a decrease in postprandial thermogenesis in normal pregnancy. Diabet Med 1993; 10: 139-145. (Pubitemid 23076021)
46. Thomas CR: Placental transfer of non-esterified fatty acids in normal and diabetic pregnancy. Biol Neonate 1987; 51: 94-101. (Pubitemid 17017674)
47. Ryan EA, Enns L: Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341-347.
48. Ktorza A, Bihoreau MT, Nurjhan N, Picon L, Girard J: Insulin and glucagon during the perinatal period: Secretion and metabolic effects on the liver. Biol Neonate 1985; 48: 204-220. (Pubitemid 16233147)
49. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR 3rd, Conover CA: The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96: 3149-3153. (Pubitemid 29148859)
50. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, Gleich GJ: Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994; 71: 560-566. (Pubitemid 24338164)
51. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC: Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999; 14(suppl 2):90-96. (Pubitemid 30040667)
52. Leipold H, Worda C, Ozbal A, Husslein P, Krampl E: First-trimester nuchal translucency screening in pregnant women who subsequently developed gestational diabetes. J Soc Gynecol Investig 2005; 12: 529-532. (Pubitemid 41395242)
53. Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH: The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2005; 25: 927-929. (Pubitemid 41494989)
54. Bartha JL, Wood J, Kyle PM, Soothill PW: The effect of metabolic control on fetal nuchal translucency in women with insulindependent diabetes: A preliminary study. Ultrasound Obstet Gynecol 2003; 21: 451-454. (Pubitemid 36605706)
55. National Collaborating Centre for Women's and Children's Health: Commissioned by the National Institute for Health and Clinical Excellence. Antenatal care: Routine care for the healthy pregnant woman. CG62: Full guidance. March 2008 (corrected June 2008).
56. ACOG Committee on Practice Bulletins: ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
57. +6 weeks of gestation. Obstet Gynecol 2008; 112: 598-605.
58. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH: Hypertensive disorders in pregnancy: Screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2010; 35: 662-670.